Literature DB >> 16146488

Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system--value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis.

D Reske1, H-F Petereit, W-D Heiss.   

Abstract

OBJECTIVES: A number of neurological syndromes may be evoked by involvement of the nervous system due to systemic diseases such as lupus erythematodes, sarcoidosis, Behçet's disease and Sjögren's syndrome (SS) and may be confounded with another chronic inflammatory disease which is restricted to the central nervous system, e.g. multiple sclerosis (MS). Because of different treatment strategies, it is important to distinguish between these different autoimmune diseases.
RESULTS: Neither clinical signs nor additional analyses such as serological findings or cerebrospinal fluid (CSF) analysis are able to differentiate between the diseases with certainty. Nevertheless, taking all findings together, diagnosis may be possible.
CONCLUSION: Here we compare typical clinical and CSF findings in MS, neurosarcoidosis, neurolupus, neuro-Behçet and nervous system involving SS with special emphasis on those findings allowing differentiation of the respective diseases by reviewing the literature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16146488     DOI: 10.1111/j.1600-0404.2005.00414.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  12 in total

Review 1.  Neuro-Behçet's syndrome: differential diagnosis and management.

Authors:  Erdal Diri; Louis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

2.  Neurosarcoidosis--a diagnostic pitfall with consequences.

Authors:  Irene Kapfhammer; Christine Armbruster; Christian Armbruster
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

3.  Neurological manifestations of connective tissue diseases mimicking multiple sclerosis.

Authors:  Sigliti-Henrietta Pelidou; Sotiris Giannopoulos; Sotiria Tzavidi; Niki Tsifetaki; Georgios Kitsos; Dimitrios Stefanou; Vassiliki Kostadima; Alexandros A Drosos; Athanassios P Kyritsis
Journal:  Rheumatol Int       Date:  2007-06-15       Impact factor: 2.631

4.  The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing.

Authors:  William H Rounds; Ann J Ligocki; Mikhail K Levin; Benjamin M Greenberg; Douglas W Bigwood; Eric M Eastman; Lindsay G Cowell; Nancy L Monson
Journal:  Front Neurol       Date:  2014-09-16       Impact factor: 4.003

Review 5.  Overview of neurosarcoidosis: recent advances.

Authors:  Renata Hebel; Mirosława Dubaniewicz-Wybieralska; Anna Dubaniewicz
Journal:  J Neurol       Date:  2014-09-07       Impact factor: 4.849

Review 6.  Psychiatric event in multiple sclerosis: could it be the tip of the iceberg?

Authors:  Moussa A Chalah; Samar S Ayache
Journal:  Braz J Psychiatry       Date:  2017-03-23       Impact factor: 2.697

7.  Primary angiitis of the CNS (PACNS) and Behçet disease.

Authors:  Peter Berlit; Markus Krämer
Journal:  Neurol Res Pract       Date:  2019-03-26

8.  Utility of lumbar puncture in diagnosis of Vogt-Koyanagi-Harada disease.

Authors:  Julie H Tsai; Somsiri Sukavatcharin; Narsing A Rao
Journal:  Int Ophthalmol       Date:  2007-03-06       Impact factor: 2.029

9.  Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment.

Authors:  Sigliti-Henrietta Pelidou; Sotirios Giannopoulos; Sotiria Tzavidi; Georgios Lagos; Athanassios P Kyritsis
Journal:  Ther Clin Risk Manag       Date:  2008-06       Impact factor: 2.423

Review 10.  Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.

Authors:  Seema Kalra; Alan Silman; Gulsen Akman-Demir; Saeed Bohlega; Afshin Borhani-Haghighi; Cris S Constantinescu; Habib Houman; Alfred Mahr; Carlos Salvarani; Petros P Sfikakis; Aksel Siva; Adnan Al-Araji
Journal:  J Neurol       Date:  2013-12-24       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.